[
  {
    "ts": "2026-01-21T11:50:00+00:00",
    "headline": "BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.",
    "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-address-115000430.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "fe593b40-b235-3c84-aa72-cebec6cb8a95",
      "content": {
        "id": "fe593b40-b235-3c84-aa72-cebec6cb8a95",
        "contentType": "STORY",
        "title": "BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market",
        "description": "",
        "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.",
        "pubDate": "2026-01-21T11:50:00Z",
        "displayTime": "2026-01-21T11:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/12543ce887a59b4ce0960c4a5982b223",
          "originalWidth": 400,
          "originalHeight": 300,
          "caption": "In development BD Neopak(TM) XtraFlow(TM) 5.5mL Glass Prefillable Syringe",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UNomiTtKfe0m9S7Tohm1OA--~B/aD0zMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/12543ce887a59b4ce0960c4a5982b223.cf.webp",
              "width": 400,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E3MZRftMfI7voPvfodtGlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/12543ce887a59b4ce0960c4a5982b223.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-address-115000430.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-address-115000430.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]